| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |